Did you know that between 2015 and 2020, over 1,000 clinical trials on medicinal cannabis were registered in the United States? (National Library of Medicine, 2024) Despite these advances, challenges remain: social stigma, regulatory barriers, and gaps in clinical training. That is why it’s essential to discuss medicinal cannabis with evidence, ethics, and professional responsibility.…
Despite Colombia’s legalization and regulation of medical cannabis, patients still face major barriers including stigma, high costs, lack of insurance coverage, and insufficient guidance for doctors, which often forces them to seek unreliable products on the informal market, putting their health at risk. Expanding insurance coverage and improving education for healthcare providers could make safe,…
Recently, I had the pleasure of joining the hosts of Global Cannabis Intelligence to discuss the dynamic and rapidly evolving cannabis landscape in Latin America. Access to Cannabis Medicine in Latin America One of the most significant developments we discussed is the progress we’ve made in patient access to cannabis-based medicines. In Colombia for example,…
In this presentation, I explore the critical role of the endocannabinoid system (ECS) in maintaining human health and its therapeutic potential through medical cannabis. I begin by reflecting on the progress of medical cannabis legalization and usage in Colombia, emphasizing the growing patient-centric focus of the industry. I underline that all advancements in cultivation, extraction,…